EP3570840
COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.1.2018EP published:
19.3.2025EP application number:
18709192.1
EPO information:
European Patent Register
Max expiry date:
18.1.2038
Title in English:
COMBINATIONS OF CABOZANTINIB AND ATEZOLIZUMAB FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCERLanguage of the patent:
English
Timeline
Today
19.1.2018EP application
19.3.2025EP Publication
Owner
Name:
Exelixis, Inc.Address:
1851 Harbor Bay Parkway, Alameda, CA 94502, US
Inventor
Name:
SCHWAB, GiselaAddress:
Hayward CA 94541, US
Name:
SCHEFFOLD, ChristianAddress:
Palo Alto CA 94306, US
Name:
HESSEL, ColinAddress:
Redwood City CA 94061, US
Priority
Number:
201762448869 PDate:
20.1.2017Country:
US
Number:
201762458447 PDate:
13.2.2017Country:
US
Classification
Categories:
A61K 31/47, A61K 39/39, A61K 9/20, A61K 39/00, A61K 39/395, A61K 45/06, A61P 35/00, A61P 35/04, C07K 16/28